Psychiatry and Mental Health - Global Neurology Academy

1-16 of 91

Nutrition and the Gut-Brain Connection in Schizophrenia
Nutrition and the Gut-Brain Connection in Schizophrenia
On the Frontlines of Schizophrenia
Nutrition and the Gut-Brain Connection in Schizophrenia
Shelina Ramnarine, PhD; Deanna L. Kelly, PharmD, BCPP
- Shelina Ramnarine, PhD
- Deanna L. Kelly, PharmD, BCPP
The Social Brain in Schizophrenia
The Social Brain in Schizophrenia
On the Frontlines of Schizophrenia
The Social Brain in Schizophrenia
Shelina Ramnarine, PhD; Michael Green, PhD
- Shelina Ramnarine, PhD
- Michael Green, PhD
Depression as a Signal of MS Progression
Depression as a Signal of MS Progression
NeuroFrontiers
Depression as a Signal of MS Progression
Challenging the Status Quo in Schizophrenia Treatment
Challenging the Status Quo in Schizophrenia Treatment
On the Frontlines of Schizophrenia
Challenging the Status Quo in Schizophrenia Treatment
Shelina Ramnarine, PhD; Stephen Marder, MD
- Shelina Ramnarine, PhD
- Stephen Marder, MD
Addressing Social and Systemic Barriers in Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
On the Frontlines of Schizophrenia
Addressing Social and Systemic Barriers in Schizophrenia
Shelina Ramnarine, PhD; Margaret Emerson, DNP, APRN, PMHNP-BC
- Shelina Ramnarine, PhD
- Margaret Emerson, DNP, APRN, PMHNP-BC
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
On the Frontlines of Schizophrenia
Delivering a Hopeful, Recovery-Oriented Schizophrenia Diagnosis
Alexandria May, PharmD, BCPS; Apurva Bhatt, MD
- Alexandria May, PharmD, BCPS
- Apurva Bhatt, MD
How Muscarinic Therapies Are Redefining Schizophrenia Care
How Muscarinic Therapies Are Redefining Schizophrenia Care
NeuroFrontiers
How Muscarinic Therapies Are Redefining Schizophrenia Care
Michael Halassa, MD, PhD
- Michael Halassa, MD, PhD
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
NeuroFrontiers
Addressing the Hidden Burden of Negative Symptoms in Schizophrenia
Alexandria May, PharmD, BCPS; Michael Halassa, MD, PhD
- Alexandria May, PharmD, BCPS
- Michael Halassa, MD, PhD
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
NeuroFrontiers
Overcoming Adherence Barriers in Schizophrenia: Strategies for Lasting Stability
Charles Turck, PharmD, BCPS, BCCCP; Tushita Mayanil, MBBS (MD)
- Charles Turck, PharmD, BCPS, BCCCP
- Tushita Mayanil, MBBS (MD)
- Melanie Yabs, PharmD, MS, BCPP
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
NeuroFrontiers
Detecting Schizophrenia Early: Clinical Challenges and Future Directions
Jeffrey A. Lieberman, MD
- Jeffrey A. Lieberman, MD
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
NeuroFrontiers
Supporting Adherence in Schizophrenia: The Role of Digital and Team-Based Tools
Charles Turck, PharmD, BCPS, BCCCP; Hannah Brown, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Hannah Brown, MD
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
NeuroFrontiers
Beyond Symptom Control: Optimizing Functional Outcomes in Schizophrenia Care
Ashley Baker, MSN, PMHNP; Stephen Marder, MD
- Ashley Baker, MSN, PMHNP
- Stephen Marder, MD
Digital Danger: Understanding AI Psychosis in Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
On the Frontlines of Schizophrenia
Digital Danger: Understanding AI Psychosis in Schizophrenia
Alexandria May, PharmD, BCPS; Ragy R. Girgis, MD, MS
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS
Identifying and Managing Violence Risk in Schizophrenia Care
Identifying and Managing Violence Risk in Schizophrenia Care
On the Frontlines of Schizophrenia
Identifying and Managing Violence Risk in Schizophrenia Care
Alexandria May, PharmD, BCPS; Ragy R. Girgis, MD, MS
- Alexandria May, PharmD, BCPS
- Ragy R. Girgis, MD, MS
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
NeuroFrontiers
Rethinking Schizophrenia Guidelines: Why It’s Time to Incorporate Novel Mechanisms
Charles Turck, PharmD, BCPS, BCCCP; Desiree Matthews, PMHNP-BC
- Charles Turck, PharmD, BCPS, BCCCP
- Desiree Matthews, PMHNP-BC
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
NeuroFrontiers
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Shelina Ramnarine, PhD; Michelle Scargle, MD
- Shelina Ramnarine, PhD
- Michelle Scargle, MD
- Margaret Emerson, DNP, APRN, PMHNP-BC

Prev
1
2
3
…
5
6
Next

1/6